Research Headlines - Replacing an enzyme to control a very rare disease

[Source: Research & Innovation] Until recently, there was no treatment specific to alpha-mannosidosis, one of the many rare diseases that jointly affect some 30 million citizens in Europe alone. Today, there is as EU-funded research developed enzyme-replacement therapy to stop the illness in its tracks, and this medicine is on the market.

from EUROPA - Syndicated Research News Feed https://ift.tt/3dvzOsF
via IFTTT